Tufts Center for the Study of Drug Development

eClinical Solutions Advances Modern Digital Trials at Engage 2023 Conference

Retrieved on: 
Thursday, November 9, 2023
Technology, Biotechnology, Health, Pharmaceutical, Professional Services, Artificial Intelligence, Practice Management, Research, Software, Data Analytics, Health Technology, Science, Data Management, Clinical Trials, Cloud, Drug development, Digital, SCE, Intelligence, Biogen, BioNTech, PwC, The Newbury Boston, Snowflake, IDC, Organization, Biometrics, Multimedia, Tufts University School of Medicine, Clinical data management, BioMarin Pharmaceutical, Medicine, Tufts Center for the Study of Drug Development, AI, Patient, Disruptive innovation, Automation

eClinical Solutions , a global provider of digital clinical software and services, will bring together prominent clinical development leaders on Thursday, November 16 and Friday, November 17 for its fifth annual client and partner conference, Engage 2023.

Key Points: 
  • eClinical Solutions , a global provider of digital clinical software and services, will bring together prominent clinical development leaders on Thursday, November 16 and Friday, November 17 for its fifth annual client and partner conference, Engage 2023.
  • Taking place at The Newbury Boston, Engage 2023 includes nearly 280 attendees representing 60 life science organizations, and features five corporate sponsors including Halloran Consulting, PwC, Flatiron, LumaBridge, and Snowflake.
  • He will share recommendations for advancing healthcare and life science digital transformation and innovation, including the AI-embedded components of a modern end-to-end digital data blueprint that delivers and demonstrates analytics value at scale.
  • For more information about Engage and to see the agenda, please visit: www.eclinicalsol.com/event/elluminate-engage/ .

Medable Wins 2023 Prix Galien Award for Best Digital Health Solution

Retrieved on: 
Monday, October 30, 2023
Technology, Research, Clinical Trials, Health Technology, Software, Biotechnology, Health, Pharmaceutical, Science, Drug development, Bristol Myers Squibb, Health technology, Incubator, ChromeOS, Creativity, Multimedia, Tufts Center for the Study of Drug Development, Digital health, DCTS, Boehringer Ingelheim, Nobel Prize, ARD International Music Competition, Patient, Pharmaceutical industry

Medable Inc. , the leading technology provider for modern clinical trials, today announced that its evidence generation platform was awarded “Best Digital Health Solution” from a field of 24 nominees at the Prix Galien USA Forum in New York City.

Key Points: 
  • Medable Inc. , the leading technology provider for modern clinical trials, today announced that its evidence generation platform was awarded “Best Digital Health Solution” from a field of 24 nominees at the Prix Galien USA Forum in New York City.
  • Worldwide, the Prix Galien Award is regarded as the equivalent of the Nobel Prize for the life science industry.
  • Winners from this year’s cohort include respected companies such as Bristol Myers Squibb, Eli Lily and Company, Novo Nordisk Inc., Boehringer Ingelheim and more.
  • View the full release here: https://www.businesswire.com/news/home/20231030126847/en/
    Medable Wins 2023 Prix Galien Award for Best Digital Health Solution (Graphic: Medable)
    Nine of the top 10 largest Contract Research Organizations (CROs) and 14 of the top 20 world’s largest pharmaceutical companies trust Medable’s platform and have deployed its technology in 300 clinical trials in 60 countries and 100+ local languages, touching the lives of more than one million patients and research participants globally.

Medable Partners with Pluto Health to Optimize Patient Experience and Improve Access to Clinical Trials

Retrieved on: 
Tuesday, October 3, 2023
Data Management, Biotechnology, Technology, Health, General Health, Security, Apps, Applications, Software, Networks, Internet, Clinical Trials, Partnership, Tufts Center for the Study of Drug Development, Clinical trial, Multimedia, Research, DCTS, Pluto, Organization, Patient, Cancer, Drug development, Female, Pharmaceutical industry, Nursing

Medable Inc. , the leading technology provider for modern clinical trials, announces an enterprise partnership with Pluto Health , a smart care coordination services company.

Key Points: 
  • Medable Inc. , the leading technology provider for modern clinical trials, announces an enterprise partnership with Pluto Health , a smart care coordination services company.
  • The strategic partnership brings together two best-in-class solutions – Pluto Health’s health coordination platform and Medable’s digitally enabled clinical trials platform – to accelerate clinical development, increase access to clinical research, and improve data quality.
  • View the full release here: https://www.businesswire.com/news/home/20231003413736/en/
    Medable Partners with Pluto Health to Optimize Patient Experience and Improve Access to Clinical Trials (Graphic: Business Wire)
    The success of a clinical trial depends on its ability to enroll a prespecified and representative number of study participants within a planned time frame while ensuring quality data is collected to meet study objectives.
  • Medable and Pluto Health’s combined technologies will streamline enrollment and retention efforts by supporting the patient experience while facilitating easier recruitment and monitoring.

Medable Ranks in Top 8% of 2023 Inc. 5000 List of America’s Fastest-Growing Private Companies

Retrieved on: 
Thursday, August 17, 2023
Research, Technology, Clinical Trials, Health Technology, Software, Biotechnology, Pharmaceutical, Health, Data Management, Science, Database, Completeness, Tufts Center for the Study of Drug Development, Microsoft, Multimedia, Patient, Chobani, Drug development, Pharmaceutical industry, Video game

Medable Inc. , the leading technology provider for patient-centric clinical trials, today announced that it ranked in the top 8 percent (#398) and was one of the top 50 software companies on the 2023 Inc. 5000 , its annual list of the fastest-growing private companies in America.

Key Points: 
  • Medable Inc. , the leading technology provider for patient-centric clinical trials, today announced that it ranked in the top 8 percent (#398) and was one of the top 50 software companies on the 2023 Inc. 5000 , its annual list of the fastest-growing private companies in America.
  • View the full release here: https://www.businesswire.com/news/home/20230817999027/en/
    Medable named #398 on Inc. 5000 (Graphic: Business Wire)
    This year’s Inc. 5000 list had a median revenue growth of 219% and the companies collectively created nearly two million jobs and $358 billion in 2022 revenue.
  • Facebook, Chobani, Under Armour, Microsoft, and many other well-known companies gained their first national exposure as honorees on the Inc. 5000.
  • The 2023 Inc. 5000 companies are ranked according to percentage revenue growth from 2019 to 2022.

Expert Speaker Lineup Revealed for Award Winning RBQM Event

Retrieved on: 
Tuesday, August 1, 2023
Linda, Operation, Associate Director of National Intelligence and Chief Information Officer, Senior, CD, Astellas Pharma, Data management, Tufts Center for the Study of Drug Development, ZS Associates, Vertex, Clinical trial, Quality management, Evolution, Clinical quality management system, Bristol Myers Squibb, Software, Research, ICH, Central Monitoring System, Parexel, AstraZeneca, Marketing, Guidance, Bayer, Alphabet song, Fellow, Drug development, Entrepreneurship, Merck Serono, ZS, Pharmaceutical industry, Management, Fast food, Tutoring, Light

KING OF PRUSSIA, Pa., Aug. 1, 2023 /PRNewswire/ -- CluePoints, the premier provider of Risk-Based Quality Management (RBQM) Software for clinical trials, has revealed the full agenda and speaker lineup for RBQMLive 2023.

Key Points: 
  • Full agenda and keynote speakers announced for industry-leading risk-based quality management event focusing on the global transformation and evolution of RBQM, sponsored by CluePoints.
  • KING OF PRUSSIA, Pa., Aug. 1, 2023 /PRNewswire/ -- CluePoints , the premier provider of Risk-Based Quality Management (RBQM) Software for clinical trials, has revealed the full agenda and speaker lineup for RBQMLive 2023.
  • RBQMLive 2023 is a free, virtual event for anyone working with, interested in, or planning to adopt risk-based approaches to clinical trial management and oversight.
  • We urge everyone to register for the free sessions and gain insight from our fantastic line-up of expert speakers, all leaders in their respective fields."

Expert Speaker Lineup Revealed for Award Winning RBQM Event

Retrieved on: 
Tuesday, August 1, 2023
Linda, Operation, Associate Director of National Intelligence and Chief Information Officer, Senior, CD, Astellas Pharma, Data management, Tufts Center for the Study of Drug Development, ZS Associates, Vertex, Clinical trial, Quality management, Evolution, Clinical quality management system, Bristol Myers Squibb, Software, Research, ICH, Central Monitoring System, Parexel, AstraZeneca, Marketing, Guidance, Bayer, Alphabet song, Fellow, Drug development, Entrepreneurship, Merck Serono, ZS, Pharmaceutical industry, Management, Fast food, Tutoring, Light

KING OF PRUSSIA, Pa., Aug. 1, 2023 /PRNewswire/ -- CluePoints, the premier provider of Risk-Based Quality Management (RBQM) Software for clinical trials, has revealed the full agenda and speaker lineup for RBQMLive 2023.

Key Points: 
  • Full agenda and keynote speakers announced for industry-leading risk-based quality management event focusing on the global transformation and evolution of RBQM, sponsored by CluePoints.
  • KING OF PRUSSIA, Pa., Aug. 1, 2023 /PRNewswire/ -- CluePoints , the premier provider of Risk-Based Quality Management (RBQM) Software for clinical trials, has revealed the full agenda and speaker lineup for RBQMLive 2023.
  • RBQMLive 2023 is a free, virtual event for anyone working with, interested in, or planning to adopt risk-based approaches to clinical trial management and oversight.
  • We urge everyone to register for the free sessions and gain insight from our fantastic line-up of expert speakers, all leaders in their respective fields."

New research highlights a significant and continued gap in achieving diversity in clinical trials of medical therapies

Retrieved on: 
Wednesday, June 21, 2023
Blas, Tufts Center for the Study of Drug Development, Takeda, Clinical trial, MBA, Research, PMP, Associate, Patient, Drug development, CSDD, Shirin David, FDA, DIA, Chief sustainability officer, Pharmaceutical industry, Management, Clario Tech

PHILADELPHIA, June 21, 2023 /PRNewswire/ -- Clario, a healthcare research technology company that delivers leading endpoint technology solutions for clinical trials, and the Tufts Center for the Study of Drug Development (CSDD) will present the results of new research highlighting critical levels of under-representation by race and ethnicity in pivotal trials supporting drugs and biologics approved between 2007 and 2021.

Key Points: 
  • Preliminary results are to be presented during the Drug Information Association (DIA) 2023 Annual Global Meeting .
  • Commenting on the research, Otis Johnson, Chief Diversity, Inclusion and Sustainability Officer, Clario, said, "lack of diversity in clinical trials means that the medicines, when approved, may not work for the underrepresented and could harm them.
  • It enables ease of trial access for a broader pool of participants with the potential to speed up trial enrollment.
  • It is also good for business, as the approved drugs can be confidently prescribed to a broader, more diverse patient population".

New research highlights a significant and continued gap in achieving diversity in clinical trials of medical therapies

Retrieved on: 
Wednesday, June 21, 2023
Blas, Tufts Center for the Study of Drug Development, Takeda, Clinical trial, MBA, Research, PMP, Associate, Patient, Drug development, CSDD, Shirin David, FDA, DIA, Chief sustainability officer, Pharmaceutical industry, Management, Clario Tech

PHILADELPHIA, June 21, 2023 /PRNewswire/ -- Clario, a healthcare research technology company that delivers leading endpoint technology solutions for clinical trials, and the Tufts Center for the Study of Drug Development (CSDD) will present the results of new research highlighting critical levels of under-representation by race and ethnicity in pivotal trials supporting drugs and biologics approved between 2007 and 2021.

Key Points: 
  • Preliminary results are to be presented during the Drug Information Association (DIA) 2023 Annual Global Meeting .
  • Commenting on the research, Otis Johnson, Chief Diversity, Inclusion and Sustainability Officer, Clario, said, "lack of diversity in clinical trials means that the medicines, when approved, may not work for the underrepresented and could harm them.
  • It enables ease of trial access for a broader pool of participants with the potential to speed up trial enrollment.
  • It is also good for business, as the approved drugs can be confidently prescribed to a broader, more diverse patient population".

MRCT Center and Medable Launch First, Comprehensive IRB/EC Review Toolkit for Decentralized Clinical Trials

Retrieved on: 
Tuesday, June 20, 2023
Data Management, Biotechnology, Technology, FDA, Health, Pharmaceutical, Medical Devices, Research, Software, Science, Clinical Trials, Faculty, Tufts Center for the Study of Drug Development, Public, ECS, Clinical trial, Data collection, Innovation, EST, Multimedia, Committee, DCT, DCTS, Harvard University, Bangladesh Technical Education Board, Ethics, Trial of the century, Harvard Medical School, Certified IRB Professional, Patient, IRB, OHRP, Office for Human Research Protections, Annual general meeting, Drug development, Hospital, Institutional review board, DIA, EC, Food, Medical device, Medicine

Medable Inc. , the leading technology provider for patient-centric clinical trials, and the Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard (MRCT Center) announce a comprehensive toolkit for Institutional Review Boards (IRBs)/Ethics Committees (ECs) to standardize decentralized clinical trial (DCT) ethics review.

Key Points: 
  • Medable Inc. , the leading technology provider for patient-centric clinical trials, and the Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard (MRCT Center) announce a comprehensive toolkit for Institutional Review Boards (IRBs)/Ethics Committees (ECs) to standardize decentralized clinical trial (DCT) ethics review.
  • The first-of-its-kind toolkit provides a common framework, tools, and best practices for uniform ethical review and approval and provides a roadmap for the ethical conduct of DCTs.
  • View the full release here: https://www.businesswire.com/news/home/20230620838809/en/
    MRCT Center and Medable Launch Comprehensive IRB/EC Review Toolkit for DCTs (Graphic: Business Wire)
    “The new DCT IRB/EC Review Toolkit will ease ethics reviews of decentralized trials by establishing commonality and removing some of the guesswork that has made DCT reviews cumbersome,” said Dr. Barbara Bierer , Professor of Medicine at Harvard Medical School and Faculty Director of the MRCT Center.
  • Medable’s customers have achieved impressive results with decentralized and hybrid trials – including 200 percent faster enrollment and 50 percent cost reductions.

Medable Vice President of Data Analytics Steve Jones Wins Esteemed Decentralized Solutions Individual of the Year

Retrieved on: 
Thursday, May 25, 2023
Software, Research, General Health, Professional Services, Pharmaceutical, Data Management, Oncology, Technology, Data Analytics, Clinical Trials, Science, Health, Other Science, Interview, Tufts Center for the Study of Drug Development, Good clinical data management practice, Medication, Silver, NDA, Good clinical practice, Multimedia, DCTS, Essay, Patient, Contract research organization, Drug development, Data, Pharmaceutical industry, FDA, III, Nursing, Biostatistics

Medable Inc. , the leading technology platform for clinical trials, today announced that Steve Jones , Medable’s vice president of data analytics, achieved the silver award in the Decentralized Solutions Individual of the Year category at PharmaTimes International Clinical Researcher of the Year awards gala in London on May 18, 2023.

Key Points: 
  • Medable Inc. , the leading technology platform for clinical trials, today announced that Steve Jones , Medable’s vice president of data analytics, achieved the silver award in the Decentralized Solutions Individual of the Year category at PharmaTimes International Clinical Researcher of the Year awards gala in London on May 18, 2023.
  • View the full release here: https://www.businesswire.com/news/home/20230525005347/en/
    Medable's Steve Jones Wins Decentralized Solutions Individual of the Year (Graphic: Business Wire)
    “Steve is one of the most innovative and experienced data scientists in the life sciences industry,” said Michelle Longmire, CEO and co-founder at Medable.
  • Jones was one of the four finalists in the “decentralized solutions'' category – notably, the first year for this category.
  • “Medable has afforded me an amazing opportunity to go beyond the data and apply it to help advance clinical research and mankind.